AI assistant
SI-BONE, Inc. — Director's Dealing 2023
Mar 2, 2023
32647_dirs_2023-03-02_0f9651aa-083b-4c30-89c7-12238f8f4549.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SI-BONE, Inc. (SIBN)
CIK: 0001459839
Period of Report: 2023-02-28
Reporting Person: FRANCIS LAURA (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-02-28 | Common Stock | M | 35000.00 | $4.32 | Acquired | 488168.00 | Direct |
| 2023-02-28 | Common Stock | S | 35000.00 | $20.2335 | Disposed | 453168.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-02-28 | Stock Option (Right to Buy) | $4.32 | M | 35000.00 | Disposed | 2025-05-25 | Common Stock (35000.00) | Direct |
| 2023-02-28 | Stock Options (Right to buy) | $22.00 | G | 9863.00 | Disposed | 2029-01-15 | Common Stock (9863.00) | Direct |
Footnotes
F1: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.
F2: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.90, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: Includes 288,428 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer'scommon stock.
F4: The shares subject to the option vest in equal monthly installments over four years commencing on May 26, 2015, subject to Reporting
Person's continued service through each relevant vesting date. The shares subject to this option may be exercised prior to vesting, subject to Issuer's right to repurchase.
F5: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.
F6: The reported transaction involves the Reporting Person's transfer of options to trusts for the benefit of Reporting Person's children.